# Innoviva, Inc. (INVA) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Innoviva, Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/INVA/mda/fy2025/): filed 2026-02-25; accession 0001193125-26-071776 (https://www.sec.gov/Archives/edgar/data/1080014/000119312526071776/inva-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/INVA/mda/fy2024/): filed 2025-02-26; accession 0000950170-25-027864 (https://www.sec.gov/Archives/edgar/data/1080014/000095017025027864/inva-20241231.htm)
- [FY 2023 MD&A](/company/INVA/mda/fy2023/): filed 2024-02-29; accession 0000950170-24-023237 (https://www.sec.gov/Archives/edgar/data/1080014/000095017024023237/inva-20231231.htm)
- [FY 2022 MD&A](/company/INVA/mda/fy2022/): filed 2023-02-28; accession 0000950170-23-005168 (https://www.sec.gov/Archives/edgar/data/1080014/000095017023005168/inva-20221231.htm)
- [FY 2021 MD&A](/company/INVA/mda/fy2021/): filed 2022-02-28; accession 0000950170-22-002169 (https://www.sec.gov/Archives/edgar/data/1080014/000095017022002169/inva-20211231.htm)

Back to /company/INVA/